跳至主要内容
临床试验/NCT01066702
NCT01066702终止3 期

A Randomized Comparison of NeoCart to Microfracture for the Repair of Articular Cartilage Injuries in the Knee

Histogenics Corporation59 个研究点 分布在 2 个国家目标入组 245 人开始时间: 2010年5月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
终止
发起方
入组人数
245
试验地点
59
主要终点
The change of physical functioning and pain as assessed by patient reported outcome measures (Knee injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC) score)

研究概览

简要总结

This confirmatory study is a prospective randomized trial comparing the efficacy and safety of an autologous chondrocyte tissue implant (NeoCart) to the surgical intervention microfracture in the treatment of cartilage defects in the knee.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 59 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • greater than 18 years old
  • symptomatic articular cartilage lesion of the femur and/or trochlea

排除标准

  • prior surgical intervention other than debridement
  • arthritis
  • clinically significant or symptomatic vascular or neurologic disorder of the lower extremities

研究组 & 干预措施

NeoCart

Experimental

Autologous cartilagenous tissue implant

干预措施: NeoCart (Biological)

Microfracture

Active Comparator

surgical intervention

干预措施: Microfracture (Procedure)

结局指标

主要结局

The change of physical functioning and pain as assessed by patient reported outcome measures (Knee injury and Osteoarthritis Outcome Score (KOOS), International Knee Documentation Committee (IKDC) score)

时间窗: one year

次要结局

  • Repair cartilage structure as measured by magnetic resonance imaging (MRI)(one year)

研究者

发起方
Histogenics Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (59)

Loading locations...

相似试验